终末期肝病症状评估量表的编制及信效度检验OA北大核心CSTPCD
Development of symptom assessment scale for patients with end-stage liver disease and its reliability and validity test
目的:编制终末期肝病症状评估量表,并检验其信效度.方法:以症状体验模型为理论基础,根据文献回顾、半结构化访谈建立初始条目池,经过德尔菲法专家函询,形成初始量表.选取河北省某三级甲等医院消化内科住院治疗的334例终末期肝病病人进行临床调查,检验量表的信效度.结果:最终形成的终末期肝病症状评估量表包括7个维度,共23个条目.量表条目水平的内容效度指数为0.833～1.000,量表水平的内容效度指数为0.971.探索性因子分析共提取7个公因子,累计方差贡献率为62.556%;验证性因子分析结果显示,量表的修正模型拟合良好.量表的Cronbach's α系数为0.859,折半信度为0.827,重测信度为0.848.结论:终末期肝病症状评估量表具有良好的信效度,可以用于评估终末期肝病病人的症状负担.
Objective:To develop the symptom assessment scale for patients with end-stage liver disease,and to test its reliability and validity.Methods:Based on the symptom experience model,the initial item pool was established according to the methods of literature review and semi-structured interview.After Delphi expert consultation,the initial scale was formed.A total of 334 patients with end-stage liver disease who were hospitalized in the department of gastroenterology of a tertiary grade A hospital in Hebei province were selected to test the reliability and validity.Results:The final version of symptom assessment scale for patients with end-stage liver disease included 7 dimensions,involving 23 items.The item-content validity index(I-CVI)ranged from 0.833 to 1.000,and scale-content validity index(S-CVI)was 0.971.The exploratory factor analysis(EFA)extracted 7 common factors,and the cumulative variance contribution rate was 62.556%.Confirmatory factor analysis showed that the model fitted well.The Cronbach's α coefficient of the scale was 0.859,the split-half reliability was 0.827,and the test-retest reliability was 0.848.Conclusion:The symptom assessment scale for patients with end-stage liver disease had good reliability and validity,which could be used to evaluate the symptom burden of patients with end-stage liver disease.
田甘露;陈泽阳;何文英
河北医科大学第二医院,河北 050000
终末期肝病症状量表信度效度
end-stage liver diseasesymptomsscalereliabilityvalidity
《护理研究》 2024 (008)
1330-1335 / 6
评论